Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : IMDS nasdaq bulletin board -- Ignore unavailable to you. Want to Upgrade?

To: jwk who wrote (3904)	12/2/1999 8:18:00 AM
From: tonto	Read Replies (1) \| Respond to of 4122

I have had the same luck you have regarding our searches. Maybe Harvard will be able to help. The agreement calls for a large commitment of units to be sold during the next 3 years. 50 to be exact. At the going rate, that equals $12,500,000 or a little over $4,000,000 a year. Imaging Diagnostic Systems Reports Sales at RSNA Medical Conference For the Millennium FORT LAUDERDALE, Fla., Dec. 1 /PRNewswire/ -- Imaging Diagnostic Systems Inc. (OTC Bulletin Board: IMDS) announced today that it has received the first signed and funded orders for its CT Laser Mammography system. The corporation Cycle of Life Technologies, based in Toronto, Canada, has signed an agreement for two systems totaling $500,000 in revenues with the delivery of two additional systems immediately following. The Cycle of Life Technologies has signed a three-year distribution agreement with a commitment of fifty systems to be delivered within two years. Their distribution channel encompasses an extensive network of international hospitals and physician practices. They are the primary suppliers for various medical services and equipment throughout Canada, Europe, South Africa and the Middle East. Cycle of Life Technologies is also involved in the development of DNA diagnostics and gene therapy with ACGT Corporation of Canada and Harvard Medical School. Imaging Diagnostic Systems has committed to commence delivery of the first CTLM systems in the first quarter of the millennium. This will be the first revenues generated for Imaging Diagnostic Systems since the inception of the company. Imaging Diagnostic Systems has developed the world's first patented laser-based mammography imaging system that utilizes state-of-the-art laser technology and proprietary computed algorithms to create contiguous cross sectional slice images of the breast without the use of compression or x-rays. Safe Harbor statement under the Private Securities Litigation Reform Act of 1995: The statements which are not historical facts contained in this press release are forward-looking statements that involve certain risks and uncertainties including, but not limited to, risks associated with the uncertainties of future events and other uncertainties detailed in the Company's filings with the Security and Exchange Commission. ------------------------------------------------------------------------ SOURCE: ÿImaging Diagnostic Systems Inc. CONTACT: ÿDeborah O'Brien of Imaging Diagnostic Systems Inc., 954-581-9800